LEO 80185 clinical trials
How each study uses LEO 80185 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2010 (3)
| Year | Studies |
|---|---|
| 2010 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Betamethasone dipropionate, calcipotriol drug combination (1)
Studies
Open first, then newest update. How each study uses LEO 80185 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp PsoriasisCompletedPhase 2LEO PharmaNCT01083758Written as LEO 80185 (Taclonex® Scalp topical suspension/Xamiol® gel)How we know
- Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp PsoriasisCompletedPhase 2LEO PharmaNCT01120223Written as LEO 80185 (Xamiol® gel/Taclonex® Scalp topical suspension)How we know
- LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With PsoriasisCompletedPhase 3LEO PharmaNCT02668692Written as LEO 80185 gelHow we know
- An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent SubjectsCompletedPhase 2LEO PharmaNCT02038569Written as LEO 80185 gelHow we know
- Dermatopharmacokinetic Trial of LEO 80185 GelCompletedPhase 1LEO PharmaNCT02605057Written as LEO 80185 gelHow we know
- Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisCompletedPhase 2LEO PharmaNCT01229098Written as LEO 80185 (Xamiol® gel/Taclonex® Scalp topical suspension)How we know